share_log

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit

EDETEK将在第十五届临床试验战略峰会上发表主题演讲
PR Newswire ·  04/30 14:38

Presentation will Address Solutions to Real-Time Management of Complex Clinical Data

演讲将讨论复杂临床数据实时管理的解决方案

PRINCETON, N.J., April 30, 2024 /PRNewswire/ -- EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and present 15th Clinical Trials Strategic Summit (CTSS), May 1-2, 2024, Boston, MA. Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. will deliver a keynote presentation entitled, "Unlock Clinical Data to Guide Agile Decision Making." This presentation takes place on Wednesday, May 1 at 1:30pm ET.

新泽西州普林斯顿,2024年4月30日 /PRNewswire/ — 为生物制药、医疗器械和诊断行业临床开发提供全面、完全集成的全球领先平台和服务的全球领先提供商EDETEK Inc. 今天宣布,它将成为白金赞助商,并将于2024年5月1日至2日在马萨诸塞州波士顿出席第15届临床试验战略峰会(CTSS)。EDETEK, Inc.产品战略与创新副总裁Munther Baara将发表题为 “解锁临床数据以指导敏捷决策” 的主题演讲。本次演讲将于美国东部时间5月1日星期三下午 1:30 举行。

"In the fast-paced world of clinical trials, the ability to swiftly unlock and interpret complex data sets is crucial for agile decision-making," said Mr. Baara. "Innovative solutions from EDETEK not only streamline data processes but also harness the power of advanced analytics to deliver actionable insights, ensuring higher quality outcomes and accelerating clinical trial lifecycles."

巴拉说:“在快节奏的临床试验世界中,快速解锁和解释复杂数据集的能力对于敏捷决策至关重要。”“EDETEK的创新解决方案不仅可以简化数据流程,还可以利用高级分析的力量来提供切实可行的见解,确保更高质量的结果并加快临床试验生命周期。”

This presentation explores EDETEK's innovative solutions that empower sponsors to seamlessly access, analyze, and act upon clinical data. Mr. Baara's presentation will highlight the role of the CONFORM informatics platform and how this innovative software tool delivers foundational and fundamental solutions in an ever-changing clinical informatics ecosystem.

本演示探讨了EDETEK的创新解决方案,这些解决方案使申办方能够无缝访问、分析临床数据并据此采取行动。Baara先生的演讲将重点介绍CONFORM信息学平台的作用,以及这种创新的软件工具如何在不断变化的临床信息学生态系统中提供基础和基础解决方案。

CONFORM is a powerful, purpose-built software platform that positively impacts the speed and quality of clinical trial execution by providing the ability to connect, collect, conform, and consume clinical trial data while conforming to state-of-the industry standards and regulations all in one, seamless, integrated solution.

CONFORM 是一款功能强大、专门构建的软件平台,通过提供连接、收集、整合和使用临床试验数据的能力,同时符合行业最新标准和法规,集于一个无缝的集成解决方案中,从而对临床试验执行的速度和质量产生积极影响。

"EDETEK provides comprehensive metadata driven solutions to fulfill an enterprise's data engineering and business analytics needs, through excellence in technology and its applications, plus deep and broad IT industry knowledge," says Jian Chen, CEO, EDETEK, Inc. "It is a privilege to participate in the 2024 CTSS conference. We are excited to discuss how our precisely targeted solutions can exceed critical data management and analysis objectives thereby helping assure quality, speed, and cost efficiencies."
Please visit us at our booth number #9.

EDETEK, Inc.首席执行官陈健说:“EDETEK通过卓越的技术及其应用,以及深入而广泛的IT行业知识,提供全面的元数据驱动解决方案,以满足企业的数据工程和业务分析需求。” 能够参加2024年CTSS会议是一种荣幸。我们很高兴地讨论我们的精确目标解决方案如何超越关键数据管理和分析目标,从而帮助确保质量、速度和成本效益。”
请访问我们的展位号 #9。

About EDETEK
Founded in 2009, EDETEK is an innovative clinical solutions company that provides high-quality technology platforms and related clinical services to pharmaceutical, biotechnology, and medical device companies. With over 450 employees on 4 continents, EDETEK's commitment to excellence remains unwavering as it collaborates with over 100 biopharmaceutical companies.

关于 EDETEK
EDETEK成立于2009年,是一家创新的临床解决方案公司,为制药、生物技术和医疗器械公司提供高质量的技术平台和相关的临床服务。EDETEK在四大洲拥有450多名员工,与100多家生物制药公司合作,对卓越的承诺坚定不移。

Learn more at or reach out to [email protected].

要了解更多信息,请访问或联系 [email protected]。

Media Contact:
John F. Kouten
JFK Communications, Inc.
908-227-4714
[email protected]

媒体联系人:
约翰·F·库滕
肯尼迪通讯公司
908-227-4714
[电子邮件保护]

SOURCE EDETEK, Inc.

来源 EDETEK, Inc.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发